Scott Forman is based out of our New York office, and focuses his practice primarily on patent litigation. He has significant experience in all stages of litigation including drafting pleadings, working on fact and expert discovery, and preparing pretrial filings.

Prior to joining Wolf Greenfield, Scott was an associate at Kenyon & Kenyon LLP, where his practice focused on Hatch-Waxman litigation, litigation involving chemical additives, prosecution of chemical, materials, and medical device patents, post-grant proceedings, and pharmaceutical patent clearance opinions.

Scott also previously worked as a patent law intern at both Alzcor Pharmaceuticals and OSI Pharmaceuticals, where he performed freedom to operate searches for potential Alzheimer’s treatments and analyzed patentability of drugs for licensing potential. At OSI Pharmaceuticals, he also worked as a chemistry intern, synthesizing small molecule organic compounds for potential use in cancer therapeutics. As an undergraduate, Scott performed synthetic inorganic chemistry research on heterobimetallic compounds for use in alternative energy applications. This research was published in the journal Inorganic Chemistry.
  • Represented automobile manufacturer in the Eastern District of Texas in patent litigation involving more than 20 patents covering automobile safety technology.
  • Led a large team of associates in review of electronic discovery, drafted privilege logs, and drafted invalidity contentions.
  • Represented manufacturer of nutritional supplements in patent investigation before the International Trade Commission.
  • Represented multinational pharmaceutical company in Hatch-Waxman litigation over patents directed to ophthalmic pharmaceutical formulations. Drafted pleadings, worked on fact and expert discovery, prepared for and second-chaired fact and expert depositions.
  • Served as lead associate in patent litigation on behalf of a supplier of chemical additives for asphalt production. Evaluated prior art, drafted invalidity contentions, drafted discovery requests and responses, prepared for and second-chaired fact and expert depositions, and prepared pretrial submissions.
  • Drafted pharmaceutical patent clearance opinions and executed freedom to operate searches on behalf of a multinational pharmaceutical company.
  • Drafted filings for post-grant proceedings, including inter partes reviews and reexaminations.
  • Conducted worldwide patent infringement risk analysis on behalf of a global telecommunications and mobile handset provider.
  • Performed pre-complaint investigations into potential infringement of patents covering GPS mapping technology, and drafted complaint against global computer software and consumer electronics company.
  • Prosecuted patents directed to medical devices, steel fabrication, and chemical compounds.
  • Evaluated patents related to nutritional supplements for potential licensing.
  • New York Intellectual Property Law Association

Articles

April 17, 2018

Patent eligibility under US scrutiny

Blogs

July 10, 2018

For Indefiniteness Challenges in District Court, Don’t Forget What You Said in IPR

March 30, 2017

PTAB to Petitioners:  Don’t Hold Back



Scientific Publications

Bennett P. Greenwood, Scott I. Forman, Gerard T. Rowe, Chun-Hsing Chen, Bruce M. Foxman & Christine M. Thomas, Multielectron Redox Activity Facilitated by Metal-Metal Interactions in Early/Late Heterobimetallics: Co/Zr Complexes Supported by Phosphinoamide Ligands, 48 INORGANIC CHEMISTRY 6251 (2009).


John R. Kenny & Scott I. Forman, The Broadest Reasonable Construction Standard and the Consideration of Claim Construction by a District Court at the Patent Trial and Appeal Board, 88 PTCJ 1084 (2014).

John R. Kenny & Scott Forman, An Update on Stays Pending PTAB Trial Proceedings, Law360, Aug. 15, 2013.


Skiing, scuba diving, soccer, NY Jets, jazz
Expand All
Scott Forman is based out of our New York office, and focuses his practice primarily on patent litigation. He has significant experience in all stages of litigation including drafting pleadings, working on fact and expert discovery, and preparing pretrial filings.

Prior to joining Wolf Greenfield, Scott was an associate at Kenyon & Kenyon LLP, where his practice focused on Hatch-Waxman litigation, litigation involving chemical additives, prosecution of chemical, materials, and medical device patents, post-grant proceedings, and pharmaceutical patent clearance opinions.

Scott also previously worked as a patent law intern at both Alzcor Pharmaceuticals and OSI Pharmaceuticals, where he performed freedom to operate searches for potential Alzheimer’s treatments and analyzed patentability of drugs for licensing potential. At OSI Pharmaceuticals, he also worked as a chemistry intern, synthesizing small molecule organic compounds for potential use in cancer therapeutics. As an undergraduate, Scott performed synthetic inorganic chemistry research on heterobimetallic compounds for use in alternative energy applications. This research was published in the journal Inorganic Chemistry.
  • Represented automobile manufacturer in the Eastern District of Texas in patent litigation involving more than 20 patents covering automobile safety technology.
  • Led a large team of associates in review of electronic discovery, drafted privilege logs, and drafted invalidity contentions.
  • Represented manufacturer of nutritional supplements in patent investigation before the International Trade Commission.
  • Represented multinational pharmaceutical company in Hatch-Waxman litigation over patents directed to ophthalmic pharmaceutical formulations. Drafted pleadings, worked on fact and expert discovery, prepared for and second-chaired fact and expert depositions.
  • Served as lead associate in patent litigation on behalf of a supplier of chemical additives for asphalt production. Evaluated prior art, drafted invalidity contentions, drafted discovery requests and responses, prepared for and second-chaired fact and expert depositions, and prepared pretrial submissions.
  • Drafted pharmaceutical patent clearance opinions and executed freedom to operate searches on behalf of a multinational pharmaceutical company.
  • Drafted filings for post-grant proceedings, including inter partes reviews and reexaminations.
  • Conducted worldwide patent infringement risk analysis on behalf of a global telecommunications and mobile handset provider.
  • Performed pre-complaint investigations into potential infringement of patents covering GPS mapping technology, and drafted complaint against global computer software and consumer electronics company.
  • Prosecuted patents directed to medical devices, steel fabrication, and chemical compounds.
  • Evaluated patents related to nutritional supplements for potential licensing.
  • New York Intellectual Property Law Association

Scientific Publications

Bennett P. Greenwood, Scott I. Forman, Gerard T. Rowe, Chun-Hsing Chen, Bruce M. Foxman & Christine M. Thomas, Multielectron Redox Activity Facilitated by Metal-Metal Interactions in Early/Late Heterobimetallics: Co/Zr Complexes Supported by Phosphinoamide Ligands, 48 INORGANIC CHEMISTRY 6251 (2009).


John R. Kenny & Scott I. Forman, The Broadest Reasonable Construction Standard and the Consideration of Claim Construction by a District Court at the Patent Trial and Appeal Board, 88 PTCJ 1084 (2014).

John R. Kenny & Scott Forman, An Update on Stays Pending PTAB Trial Proceedings, Law360, Aug. 15, 2013.

Articles

April 17, 2018

Patent eligibility under US scrutiny

Blogs

July 10, 2018

For Indefiniteness Challenges in District Court, Don’t Forget What You Said in IPR

March 30, 2017

PTAB to Petitioners:  Don’t Hold Back



Skiing, scuba diving, soccer, NY Jets, jazz